Prostate cancer cases have been on the rise in recent years, increasing 3% annually since 2014 – and now former President Joe Biden is one of the more than 300,000 men to be diagnosed this year. Biden ...

At 7.3 years’ median follow-up, cabazitaxel failed to improve clinical PFS (62.8% vs 67.2%), metastasis-free survival, or overall survival versus androgen deprivation therapy plus radiotherapy.

Cancers Symposium, and the updates were full of hope for people with advanced prostate cancer. CURE highlights two studies ...

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.

Joe Biden has been diagnosed with an "aggressive form" of prostate cancer. Biden’s team shared a statement on Sunday that the former president was experiencing "increasing urinary symptoms" ahead of ...

While prognoses for prostate cancer patients were once measured in months, experts say that advances in treatment and diagnosis now improve survival by years. By Gina Kolata Prostate cancer experts ...

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...

There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...